相关实验视频

Updated: May 11, 2026

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

针对病毒病毒的疫苗开发现状

Amber Rastogi^1,2, Manoj Kumar^3,4

¹Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh, 160036, India.

Advances in experimental medicine and biology

|May 27, 2024

概括

针对病毒 (MPXV) 的疫苗正在不断发展,新一代的疫苗如修改后的安卡拉-巴伐利亚北欧疫苗 (MVA-BN) 提供了更好的安全性和有效性. 计算方法也在开发MPXV的多表位疫苗.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

麻疹病毒 (MPXV) 是Poxviridae家族的一种成员,导致动物性麻疹 (Mpox),全球死亡率为0-11%,不成比例地影响儿童.
现有的天花疫苗 (第一代和第二代疫苗病毒疫苗) 提供对MPXV的保护,但与不良影响有关.

研究的目的:

提供针对MPXV的疫苗当前状态的概述.
突出不同疫苗代的开发和有效性以及MPXV预防的新计算方法.

主要方法:

对MPXV疫苗,包括第一,第二和第三代疫苗的现有文献的审查.
对改性疫苗安卡拉-巴伐利亚北欧 (MVA-BN) 疫苗的安全性和有效性概况的分析.
探索设计针对MPXV蛋白质的多表位疫苗的计算研究.

主要成果:

第三代MVA-BN疫苗,如Imvanex,Imvamune和JYNNEOS,表现出较少的副作用和显著的中和抗体产生.
计算研究已经成功地通过将各种MPXV衍生的表位细胞 (B细胞,CTL,CD8+,CD4+) 联系起来,设计了多表位细胞疫苗.
由于MPXV病例的增加,世界卫生组织于2022年5月宣布全球卫生紧急情况,强调需要有效的疫苗.

结论:

由于其有利的安全性和免疫性,MVA-BN疫苗代表了MPXV预防的重大进展.
多个表位组的疫苗设计提供了一个有希望的未来战略,通过向多个病毒组件来对抗MPXV.
持续研究和开发安全有效的MPXV疫苗至关重要,特别是考虑到最近的全球卫生紧急情况.

关键词:

在B细胞中,B细胞是细胞毒性T淋巴细胞吉尼奥斯 (Jynneos) 是一个古老的城市.麻疹病毒的病毒.基于多个表位素的疫苗.疫苗病毒是疫苗病毒.

更多相关视频

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3

Published on: April 13, 2009

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

相关概念视频

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...